These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 122391)

  • 21. Role of GABA in the striatal output system: globus pallidus, nucleus entopeduncularis, substantia nigra and nucleus subthalamicus.
    Scheel-Krüger J; Magelund G; Olianas MC
    Adv Biochem Psychopharmacol; 1981; 30():165-86. PubMed ID: 7036675
    [No Abstract]   [Full Text] [Related]  

  • 22. Functional interaction between rat substantia nigra and striatum: GABA and dopamine interrelation.
    Racagni G; Bruno F; Cattabeni F; Maggi A; Di Giulio AM; Parenti M; Groppetti A
    Brain Res; 1977 Oct; 134(2):353-8. PubMed ID: 890495
    [No Abstract]   [Full Text] [Related]  

  • 23. Rapid behavioural and biochemical effects of tetanus toxin microinjected into the substantia nigra: a dual role for GABA?
    James TA; Collingridge GL
    Neurosci Lett; 1979 Feb; 11(2):205-8. PubMed ID: 460688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. gamma-Aminobutyric acid release in the globus pallidus in vivo after a 6-hydroxydopamine lesion in the substantia nigra of the rat.
    Segovia J; Tossman U; Herrera-Marschitz M; Garcia-Munoz M; Ungerstedt U
    Neurosci Lett; 1986 Oct; 70(3):364-8. PubMed ID: 3022198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constraints on inferring neurochemical involvement in behavior.
    Dismukes RK
    Neurosci Res Program Bull; 1978 Dec; 16(4):580-4. PubMed ID: 35765
    [No Abstract]   [Full Text] [Related]  

  • 26. Regulation of nigro-striatal dopaminergic neurotransmission in the rat.
    Dray A; Fowler LJ; Oakley NR; Simmonds MA; Tanner T
    Neuropharmacology; 1977; 16(7-8):511-8. PubMed ID: 199852
    [No Abstract]   [Full Text] [Related]  

  • 27. Gabaergic regulation of nigrostriatal neurons: coupling of benzodiazepine and GABA receptors.
    Wood PL; Etienne P; Lal S; Nair NP
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):471-4. PubMed ID: 6298891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of dopamine in the striatum, with a consideration of thalamic inputs.
    McLennan H
    Appl Neurophysiol; 1979; 42(1-2):40-2. PubMed ID: 222206
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence for a role of nigral gamma-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase.
    Gale K; Costa E; Toffano G; Hong JS; Guidotti A
    J Pharmacol Exp Ther; 1978 Jul; 206(1):29-37. PubMed ID: 26799
    [No Abstract]   [Full Text] [Related]  

  • 30. Involvement of the nigral output pathways in the inhibitory control of the substantia nigra over generalized non-convulsive seizures in the rat.
    Depaulis A; Vergnes M; Liu Z; Kempf E; Marescaux C
    Neuroscience; 1990; 39(2):339-49. PubMed ID: 2128373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neurons in the rat.
    Agid Y; Guyenet P; Glowinski J; Beaujouan JC; Javoy F
    Brain Res; 1975 Mar; 86(3):488-92. PubMed ID: 1116013
    [No Abstract]   [Full Text] [Related]  

  • 32. Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system.
    Scheel-Krüger J
    Acta Neurol Scand Suppl; 1986; 107():1-54. PubMed ID: 3014800
    [No Abstract]   [Full Text] [Related]  

  • 33. Quantification of lesion-induced dopaminergic supersensitivity using the rotational model in the mouse.
    Mandel RJ; Randall PK
    Brain Res; 1985 Mar; 330(2):358-63. PubMed ID: 3921193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GABAergic and dopaminergic systems of the substantia nigra and amygdaloid kindling in cats.
    Kaijima M; Le Gal La Salle G; Tanaka T; Yonemasu Y
    Folia Psychiatr Neurol Jpn; 1985; 39(3):317-9. PubMed ID: 3938442
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of dopaminergic denervation and transplant-derived reinnervation on a marker of striatal GABAergic function.
    Segovia J; Meloni R; Gale K
    Brain Res; 1989 Jul; 493(1):185-9. PubMed ID: 2505886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unilateral electrolytic lesions of the substantia nigra cause contralateral circling in rats.
    Schwartz WJ; Gunn RH; Sharp FR; Evarts EV
    Brain Res; 1976 Mar; 105(2):358-61. PubMed ID: 1260449
    [No Abstract]   [Full Text] [Related]  

  • 37. Excitotoxicity of NMDA and kainic acid is modulated by nigrostriatal dopaminergic fibres.
    Chapman AG; Dürmuller N; Lees GJ; Meldrum BS
    Neurosci Lett; 1989 Dec; 107(1-3):256-60. PubMed ID: 2515501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are bilateral nigrostriatal dopaminergic pathways functionally linked in the rat brain? A microdialysis study in conscious rats.
    Santiago M; Cano J; Westerink BH
    Brain Res; 1993 Nov; 628(1-2):187-92. PubMed ID: 8313146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GABAergic denervation of rat substantia nigra: functional and pharmacological properties.
    Gale K; Iadarola MJ
    Brain Res; 1980 Feb; 183(1):217-23. PubMed ID: 6244049
    [No Abstract]   [Full Text] [Related]  

  • 40. Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications.
    Gale K; Casu M
    Mol Cell Biochem; 1981 Sep; 39():369-405. PubMed ID: 6118827
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.